×
ADVERTISEMENT

FEBRUARY 13, 2024

Preventive Therapies for Respiratory Syncytial Virus

Updates and Challenges

Drew Goodrich, PharmD, BCPPS, RPh
Clinical Pharmacy Specialist
Tufts Medical Center
Boston, Massachusetts
Kaylee Goodrich, PharmD, BCPS, RPh
Senior Pharmacist
Brigham and Women’s Hospital
Boston, Massachusetts

Respiratory syncytial virus (RSV) is a prevalent pathogen that presents as a minor common cold in most individuals. However, it is known to pose a higher risk to certain patient populations including neonates, infants, and small children, especially with certain risk factors, and adults 60